Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 406
IPSCIO Record ID: 6495
IPSCIO Record ID: 2882
IPSCIO Record ID: 286035
The Licensor of Ireland shall remain proprietor of the Licensors Glucose Monitor Technology but grants to Licensee for the term a sole and exclusive license in the territory, with the right to grant sublicenses, to research, develop, manufacture, have manufactured for Licensee, import and have imported, use, sell, offer for sale and otherwise commercialize the Glucose Monitor Technology, Licensors interest in the joint improvements in the field and the products.
Licensor grants an exclusive license in the territory solely for use in connection with the sale of the product, for the term to use any Licensor trademark, if any, which relates to the Licensors Glucose Monitor Technology applicable to the product.
This agreement includes a non-exclusive grant back to Licensor from Licensee.
Licensor is knowledgeable in the development of devices and methods for directly or indirectly monitoring the concentration of glucose in a subject and has developed unique monitoring devices and methods.
The patents are for Analyte Controlled Liquid Delivery Device and Analyte Monitor; and, Improved Glucose Monitor.
IPSCIO Record ID: 29404
At the time of execution of the Master Services and Supply Agreement in October 2007, the License Agreement was amended to grant the Company a License to certain new patents outside of such field of use.
IPSCIO Record ID: 26981
Licensed Trademarks means the Masimo Set product designation and word mark(s).
IPSCIO Record ID: 3240
The Licensor also granted the Licensee a non-exclusive, perpetual and worldwide license, with sublicense rights, to use Masimo SETÂ® for the measurement of vital signs in the Licensee Market.
Pursuant to the Cross-Licensing Agreement, the Licensor has licensed from the Licensee the right to make and distribute products in the Licensor Market that utilize rainbowÂ® technology for the measurement of only carbon monoxide, methemoglobin, fractional arterial oxygen saturation and hemoglobin, which includes hematocrit
RainbowÂ® SET platform utilizing both Masimo SETÂ® and licensed rainbowÂ® technology, includes devices cleared by the U.S. Food and Drug Administration, to noninvasively and continuously monitor multiple measurements that previously required invasive or complicated procedures.
IPSCIO Record ID: 7331
Under the Agreement with the Licensee, the Licensor will grant an exclusive, worldwide License for the use of technology to produce and market a prothrombin blood clotting measuring device.
The development contract contributes over $2 million, over an 18-month period, and culminates in the delivery of the initial batch of units for market launch during calendar year 2005.
The prothrombin time test belongs to a group of blood tests that assess the clotting ability of blood. The test is also known as the pro time or PT test.
Prothrombin is used by patients undergoing warfarin/coumadin anticoagulation therapy after a heart attack or stroke to ensure that drug levels are maintained at optimum levels.
Prothrombin blood clotting measuring device is a minimally-invasive, accurate and safe, characteristic measuring device for heart attack and stroke sufferers.